Measuring Users' Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study.
BACKGROUND
Despite the theoretical potential of mHealth solutions in the treatment of patients with schizophrenia, there remains a lack of technological tools in clinical practice.


OBJECTIVE
The aim of this study was to measure the receptivity of patients, informal carers, and clinicians to a European integral intervention model focused on patients with persistent positive symptoms: Mobile Therapeutic Attention for Patients with Treatment-Resistant Schizophrenia (m-RESIST).


METHODS
Before defining the system requirements, a qualitative study of the needs of outpatients with treatment-resistant schizophrenia was carried out in Spain, Israel, and Hungary. We analyzed the opinions of patients, informal carers, and clinicians concerning the services originally intended to be part of the solution. A total of 9 focus groups (72 people) and 35 individual interviews were carried out in the 3 countries, using discourse analysis as the framework.


RESULTS
A webpage and an online forum were perceived as suitable to get both reliable information on the disease and support. Data transmission by a smart watch (monitoring), Web-based visits, and instant messages (clinical treatment) were valued as ways to improve contact with clinicians. Alerts were appreciated as reminders of daily tasks and appointments. Avoiding stressful situations for outpatients, promoting an active role in the management of the disease, and maintaining human contact with clinicians were the main suggestions provided for improving the effectiveness of the solution.


CONCLUSIONS
Positive receptivity toward m-RESIST services is related to its usefulness in meeting user needs, its capacity to empower them, and the possibility of maintaining human contact.
Parc Sanitari Sant Joan de Déu, CIBERSAM G11, Barcelona, Spain. mehuerta@pssjd.org.
Elena
http://orcid.org/0000-0003-4134-0637
E
Huerta-Ramos
Maria Soledad
http://orcid.org/0000-0003-1150-5875
MS
Escobar-Villegas
Katya
http://orcid.org/0000-0003-2875-4456
K
Rubinstein
Zsolt Szabolcs
http://orcid.org/0000-0003-0103-5064
ZS
Unoka
Eva
http://orcid.org/0000-0003-1100-7489
E
Grasa
Margarita
http://orcid.org/0000-0001-6367-4502
M
Hospedales
Erika
http://orcid.org/0000-0001-5760-7389
E
Jääskeläinen
Elena
http://orcid.org/0000-0002-5845-5636
E
Rubio-Abadal
Asaf
http://orcid.org/0000-0003-1205-6557
A
Caspi
István
http://orcid.org/0000-0002-9464-4709
I
Bitter
Jesus
http://orcid.org/0000-0002-5955-9920
J
Berdun
Jussi
http://orcid.org/0000-0002-8752-2041
J
Seppälä
Susana
http://orcid.org/0000-0001-6792-1080
S
Ochoa
Kata
http://orcid.org/0000-0002-3229-1637
K
Fazekas
Iluminada
http://orcid.org/0000-0003-2562-711X
I
Corripio
Judith
http://orcid.org/0000-0002-1746-7737
J
Usall
intervention model; mHealth solution; needs assessment; qualitative research; treatment-resistant schizophrenia
Schizophr Res. 2014 Jun;156(1):96-106
24746468
Psychiatry (Edgmont). 2007 Jul;4(7):28-37
20526405
Telemed J E Health. 2015 Dec;21(12 ):1038-41
26171663
Schizophr Bull. 2003;29(2):201-10
14552497
Int J Soc Psychiatry. 2014 May;60(3):304-10
23680763
J Med Internet Res. 2013 Apr 05;15(4):e60
23563184
Schizophr Bull. 2012 May;38(3):384-5
22234487
Acta Psychiatr Scand. 1995 Oct;92(4):285-93
8848954
Actas Esp Psiquiatr. 2001 May-Jun;29(3):165-71
11412491
Acta Psychiatr Scand. 2001 Jan;103(1):45-51
11202128
J Psychiatr Ment Health Nurs. 2015 Dec;22(10 ):811-20
26176646
J Med Assoc Thai. 2006 Sep;89 Suppl 3:S13-9
17718264
J Clin Psychiatry. 1999;60 Suppl 12:4-8
10372602
Schizophr Bull. 2014 Nov;40(6):1244-53
24609454
Soc Psychiatry Psychiatr Epidemiol. 2005 Aug;40(8):628-34
16096697
Indian J Psychiatry. 2015 Apr-Jun;57(2):181-9
26124525
Acta Psychiatr Scand. 2001 May;103(5):370-9
11380307
J Med Internet Res. 2013 Oct 07;15(10):e216
24100091
Schizophr Bull. 2014 Apr;40 Suppl 3:S165-94
24778411
Int J Med Inform. 2014 Apr;83(4):264-72
24507762
Eur Neuropsychopharmacol. 2011 Sep;21(9):655-79
21896369
Psychol Serv. 2007 Aug;4(3):202-224
26321884
Psychiatr Serv. 1995 Aug;46(8):801-6
7583481
Rev Bras Psiquiatr. 2007 Oct;29 Suppl 2:S41-7
18157433
Int Clin Psychopharmacol. 2014 Mar;29(2):63-76
23995856
Bull World Health Organ. 2001;79(4):373-4
11357217
Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(1):53-7
25909790
J Ment Health. 2015;24(5):321-32
26017625
Soc Psychiatry Psychiatr Epidemiol. 2008 Aug;43(8):612-8
18340397
Schizophr Bull. 1996;22(1):15-25
8685657
BMC Psychiatry. 2013 Nov 01;13:279
24180273
Int J Soc Psychiatry. 2010 Jul;56(4):424-35
19628556
Schizophr Bull. 2015 Mar;41(2):440-8
24375458
Telemed J E Health. 2005 Dec;11(6):675-83
16430387
J Med Internet Res. 2016 Apr 22;18(4):e92
27105939
Schizophr Bull. 2012 May;38(3):414-25
22080492
Indian J Psychiatry. 2004 Jul;46(3):244-55
21224906
Schizophr Bull. 1987;13(2):261-76
3616518
Eur J Neurol. 2012 Jan;19(1):155-62
22175760
Soc Psychiatry Psychiatr Epidemiol. 2016 Apr;51(4):617-25
26155899